Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
Public ClinicalTrials.gov record NCT03841331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
Study identification
- NCT ID
- NCT03841331
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 233 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 22, 2019 (Actual)
- Primary completion
- Dec 10, 2019 (Actual)
- Completion
- Jan 21, 2020 (Actual)
- Last update posted
- May 20, 2021
2019 – 2020
United States locations
- U.S. sites
- 41
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site 221 | Hot Springs | Arkansas | 72022 | — |
| Study Site 823 | Bakersfield | California | 93301 | — |
| Study Site 204 | Fremont | California | 94538 | — |
| Study Site 803 | Los Angeles | California | 90045 | — |
| Study Site 820 | Centennial | Colorado | 80112 | — |
| Study Site 804 | Denver | Colorado | 80210 | — |
| Study Site 811 | Aventura | Florida | 33180 | — |
| Study Site 801 | Jacksonville | Florida | 32256 | — |
| Study Site 807 | Miami | Florida | 33137 | — |
| Study Site 331 | Miami | Florida | 33144 | — |
| Study Site 824 | Sarasota | Florida | 34239 | — |
| Study Site 818 | West Palm Beach | Florida | 33406 | — |
| Study Site 349 | Savannah | Georgia | 31406 | — |
| Study Site 814 | Indianapolis | Indiana | 46250 | — |
| Study Site 808 | Brighton | Massachusetts | 02135 | — |
| Study Site 822 | Rolla | Missouri | 65401 | — |
| Study Site 371 | Saint Joseph | Missouri | 64506 | — |
| Study Site 817 | St Louis | Missouri | 63110 | — |
| Study Site 821 | Bellevue | Nebraska | 68123 | — |
| Study Site 813 | Las Vegas | Nevada | 89128 | — |
| Study Site 387 | Las Vegas | Nevada | 89148 | — |
| Study Site 816 | Morristown | New Jersey | 07960 | — |
| Study Site 121 | Ocean Township | New Jersey | 07712 | — |
| Study Site 507 | Brooklyn | New York | 11203 | — |
| Study Site 802 | The Bronx | New York | 10458 | — |
| Study Site 341 | High Point | North Carolina | 27262 | — |
| Study Site 810 | Raleigh | North Carolina | 27612 | — |
| Study Site 524 | Dublin | Ohio | 43016 | — |
| Study Site 116 | Portland | Oregon | 97202 | — |
| Study Site 522 | Pittsburgh | Pennsylvania | 15213 | — |
| Study Site 345 | Johnston | Rhode Island | 02919 | — |
| Study Site 815 | Warwick | Rhode Island | 02886 | — |
| Study Site 805 | Nashville | Tennessee | 37215 | — |
| Study Site 365 | Austin | Texas | 78745 | — |
| Study Site 120 | Dallas | Texas | 75231 | — |
| Study Site 819 | Fort Worth | Texas | 76244 | — |
| Study Site 359 | Pflugerville | Texas | 78660 | — |
| Study Site 809 | San Antonio | Texas | 78229 | — |
| Study Site 217 | Norfolk | Virginia | 23502 | — |
| Study Site 806 | Spokane | Washington | 99202 | — |
| Study Site 812 | Walla Walla | Washington | 09362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03841331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2021 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03841331 live on ClinicalTrials.gov.